CNTX
Price
$1.48
Change
-$0.04 (-2.63%)
Updated
Jan 16, 11:16 AM (EDT)
Capitalization
139.66M
68 days until earnings call
Intraday BUY SELL Signals
PRQR
Price
$1.69
Change
+$0.10 (+6.33%)
Updated
Jan 16, 11:46 AM (EDT)
Capitalization
166.45M
34 days until earnings call
Intraday BUY SELL Signals
Interact to see
Advertisement

CNTX vs PRQR

Header iconCNTX vs PRQR Comparison
Open Charts CNTX vs PRQRBanner chart's image
Context Therapeutics
Price$1.48
Change-$0.04 (-2.63%)
Volume$300
Capitalization139.66M
ProQR Therapeutics
Price$1.69
Change+$0.10 (+6.33%)
Volume$3.32K
Capitalization166.45M
CNTX vs PRQR Comparison Chart in %
CNTX
Daily Signal:
Gain/Loss:
PRQR
Daily Signal:
Gain/Loss:
View a ticker or compare two or three
VS
CNTX vs. PRQR commentary
Jan 16, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CNTX is a Hold and PRQR is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jan 16, 2026
Stock price -- (CNTX: $1.52 vs. PRQR: $1.58)
Brand notoriety: CNTX and PRQR are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CNTX: 86% vs. PRQR: 90%
Market capitalization -- CNTX: $139.66M vs. PRQR: $166.45M
CNTX [@Biotechnology] is valued at $139.66M. PRQR’s [@Biotechnology] market capitalization is $166.45M. The market cap for tickers in the [@Biotechnology] industry ranges from $111.36B to $0. The average market capitalization across the [@Biotechnology] industry is $2.26B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CNTX’s FA Score shows that 1 FA rating(s) are green whilePRQR’s FA Score has 1 green FA rating(s).

  • CNTX’s FA Score: 1 green, 4 red.
  • PRQR’s FA Score: 1 green, 4 red.
According to our system of comparison, CNTX is a better buy in the long-term than PRQR.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CNTX’s TA Score shows that 6 TA indicator(s) are bullish while PRQR’s TA Score has 4 bullish TA indicator(s).

  • CNTX’s TA Score: 6 bullish, 4 bearish.
  • PRQR’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CNTX is a better buy in the short-term than PRQR.

Price Growth

CNTX (@Biotechnology) experienced а -5.00% price change this week, while PRQR (@Biotechnology) price change was -24.76% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +0.72%. For the same industry, the average monthly price growth was +2.38%, and the average quarterly price growth was +41.99%.

Reported Earning Dates

CNTX is expected to report earnings on Mar 25, 2026.

PRQR is expected to report earnings on Feb 19, 2026.

Industries' Descriptions

@Biotechnology (+0.72% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
PRQR($166M) has a higher market cap than CNTX($140M). CNTX YTD gains are higher at: 3.401 vs. PRQR (-21.782). CNTX has higher annual earnings (EBITDA): -30.19M vs. PRQR (-38.15M). PRQR has more cash in the bank: 107M vs. CNTX (76.9M). CNTX has less debt than PRQR: CNTX (140K) vs PRQR (16.5M). PRQR has higher revenues than CNTX: PRQR (15.5M) vs CNTX (0).
CNTXPRQRCNTX / PRQR
Capitalization140M166M84%
EBITDA-30.19M-38.15M79%
Gain YTD3.401-21.782-16%
P/E RatioN/AN/A-
Revenue015.5M-
Total Cash76.9M107M72%
Total Debt140K16.5M1%
FUNDAMENTALS RATINGS
PRQR: Fundamental Ratings
PRQR
OUTLOOK RATING
1..100
59
VALUATION
overvalued / fair valued / undervalued
1..100
25
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
91
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
85

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CNTXPRQR
RSI
ODDS (%)
Bearish Trend 1 day ago
87%
Bullish Trend 1 day ago
90%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
89%
Bullish Trend 1 day ago
80%
Momentum
ODDS (%)
Bullish Trend 1 day ago
87%
Bearish Trend 1 day ago
90%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bearish Trend 1 day ago
87%
TrendWeek
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
84%
TrendMonth
ODDS (%)
Bullish Trend 1 day ago
86%
Bearish Trend 1 day ago
83%
Advances
ODDS (%)
Bullish Trend 3 days ago
88%
Bullish Trend 10 days ago
84%
Declines
ODDS (%)
Bearish Trend 25 days ago
88%
Bearish Trend 4 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
82%
Aroon
ODDS (%)
Bullish Trend 1 day ago
74%
Bearish Trend 1 day ago
82%
View a ticker or compare two or three
Interact to see
Advertisement
CNTX
Daily Signal:
Gain/Loss:
PRQR
Daily Signal:
Gain/Loss:
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
WTLLF4.21N/A
N/A
Water Intelligence PLC
RNECF15.50N/A
N/A
Renesas Electronics Corp
YITYY1.35N/A
N/A
YIT OYJ
PANHF2.00-0.05
-2.44%
Ping An Healthcare & Technology Co Ltd.
HVGDF0.04-0.01
-25.77%
Harvest Gold Corp.

CNTX and

Correlation & Price change

A.I.dvisor tells us that CNTX and ZURA have been poorly correlated (+31% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CNTX and ZURA's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CNTX
1D Price
Change %
CNTX100%
-3.18%
ZURA - CNTX
31%
Poorly correlated
-12.66%
PROK - CNTX
29%
Poorly correlated
-4.39%
CRBP - CNTX
28%
Poorly correlated
-1.09%
PRQR - CNTX
28%
Poorly correlated
-3.66%
NAMS - CNTX
28%
Poorly correlated
-0.28%
More

PRQR and

Correlation & Price change

A.I.dvisor indicates that over the last year, PRQR has been loosely correlated with RGNX. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if PRQR jumps, then RGNX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To PRQR
1D Price
Change %
PRQR100%
-3.66%
RGNX - PRQR
49%
Loosely correlated
-7.96%
BEAM - PRQR
46%
Loosely correlated
-9.49%
RNAC - PRQR
44%
Loosely correlated
-3.66%
ETHZ - PRQR
44%
Loosely correlated
+0.18%
DNLI - PRQR
44%
Loosely correlated
+2.79%
More